IDL Diagnostics attended the European Association of Urology (EAU) 2026 conference in London last week. We had valuable discussions with physicians who use our diagnostic biomarkers in clinical practice and research.
A big thank you to everyone we met at EAU26! We received many insightful inputs that will guide our ongoing development and help us stay focused on what matters most: delivering better, faster, and more accessible diagnostics for patients.
Anders Hultman, Gustav Sten, Xia Jiang and Marie Torstensson have been in Shanghai, China, to meet our partners within CLIA. Currently, we have one product on the market, TPS CLIA, as well as two products in development: TK1 CLIA and UBC CLIA. The purpose of the...
VD Anders Hultman och CFO Ellen Dittberner presenterar bolagets resultat för Q4’25 - 26 februari 2026 Q4 Interview: Redeye pratar med VD Anders Hultman
Förra veckan deltog IDL Diagnostics som utställare på WHX Labs Dubai tillsammans med concile som en del av det nyligen offentliggjorda samriskbolaget. Huvudfokus ligger på att leverera flera biomarkörer över olika POC-läsarkonfigurationer och att stödja infektion,...
